A robust partial least squares method with applications

Partial least squares regression (PLS) is a linear regression technique developed to relate many regressors to one or several response variables. Robust methods are introduced to reduce or remove the effect of outlying data points. In this paper we show that if the sample covariance matrix is properly robustified further robustification of the linear regression steps of the PLS algorithm becomes unnecessary. The robust estimate of the covariance matrix is computed by searching for outliers in univariate projections of the data on a combination of random directions (Stahel-Donoho) and specific directions obtained by maximizing and minimizing the kurtosis coefficient of the projected data, as proposed by Peña and Prieto (2006). It is shown that this procedure is fast to apply and provides better results than other procedures proposed in the literature. Its performance is illustrated by Monte Carlo and by an example, where the algorithm is able to show features of the data which were undetected by previous methods.

Diseño de un curso de e-learning en cartografía temática

Los grandes avances en las nuevas tecnologías, evidentes en materias técnicas y científicas, repercuten también en campos menos visibles para los profesionales de la topografía y cartografía. La educación también se ve afectada y, como consecuencia de ello, surgen nuevas modalidades de enseñanza como el e-learning. Su potencial es incuestionable, pues rompe con barreras espaciales y temporales. Sin embargo, plantear cursos de este tipo no está exento de dificultades, pues exige una adaptación a las particularidades del medio y establecer un nuevo modelo de enseñanza-aprendizaje. En esta exposición se presentan las consideraciones realizadas por la Universidad Politécnica de Madrid en el diseño de un curso e-learning de Cartografía Temática ofrecido por el Instituto Geográfico Nacional, incidiendo en las ventajas de aplicar estándares en la gestión de contenidos y el uso de plataformas educativas virtuales que los acepten

Past 200 kyr hydroclimate variability in the western Mediterranean and its connection to the African Humid Periods

The Iberian Peninsula is located at the intersection between the subtropical and temperate climate zones and the paleoclimate records from this region are key to elucidate the varying humidity and changing dominance of atmospheric circulation patterns in the Mediterranean-North African region in the past. Here we present a quantitative hydroclimate reconstruction for the last ca. 200 kyr from southern Iberian Peninsula based on pollen data from the Padul lake sediment record. We use the newly developed Scale-normalized Significant Zero crossing (SnSiZer) method to detect not only the statistically significant precipitation changes but also to estimate the relative magnitude of these oscillations in our reconstruction. We identify six statistically significant main humid phases, termed West Mediterranean Humid Periods (WMHP 1-6). These humid periods correlate with other West/Central Mediterranean paleohydrological records, suggesting that similar climatic factors affected different areas of the Mediterranean. In addition, the WMPHs are roughly coeval with the African Humid Periods (AHPs) during high seasonality, suggesting the same North Atlantic ocean-atmospheric dynamics and orbital forcing as main drivers of both areas. In contrast, during low seasonality periods, the West Mediterranean still appears to be affected by the westerlies and the local Mediterranean rainfall systems with moderate-to-high precipitation, whereas West Africa was characterized by droughts.Peer reviewe

Controlled delivery of tauroursodeoxycholic acid from biodegradable microspheres slows retinal degeneration and vision loss in P23H rats

Successful drug therapies for treating ocular diseases require effective concentrations of neuroprotective compounds maintained over time at the site of action. The purpose of this work was to assess the efficacy of intravitreal controlled delivery of tauroursodeoxycholic acid (TUDCA) encapsulated in poly(D, L-lactic-co-glycolic acid) (PLGA) microspheres for the treatment of the retina in a rat model of retinitis pigmentosa. PLGA microspheres (MSs) containing TUDCA were produced by the O/W emulsion-solvent evaporation technique. Particle size and morphology were assessed by light scattering and scanning electronic microscopy, respectively. Homozygous P23H line 3 rats received a treatment of intravitreal injections of TUDCA-PLGA MSs. Retinal function was assessed by electroretinography at P30, P60, P90 and P120. The density, structure and synaptic contacts of retinal neurons were analyzed using immunofluorescence and confocal microscopy at P90 and P120. TUDCA-loaded PLGA MSs were spherical, with a smooth surface. The production yield was 78%, the MSs mean particle size was 23 mu m and the drug loading resulted 12.5 +/- 0.8 mu g TUDCA/mg MSs. MSs were able to deliver the loaded active compound in a gradual and progressive manner over the 28-day in vitro release study. Scotopic electroretinografic responses showed increased ERG a- and b-wave amplitudes in TUDCA-PLGA-MSstreated eyes as compared to those injected with unloaded PLGA particles.TUDCA-PLGAMSs- treated eyes showed more photoreceptor rows than controls. The synaptic contacts of photoreceptors with bipolar and horizontal cells were also preserved in P23H rats treated with TUDCA-PLGA MSs. This work indicates that the slow and continuous delivery of TUDCA from PLGA-MSs has potential neuroprotective effects that could constitute a suitable therapy to prevent neurodegeneration and visual loss in retinitis pigmentosa

Zero-Shot Multi-View Indoor Localization via Graph Location Networks

Indoor localization is a fundamental problem in location-based applications. Current approaches to this problem typically rely on Radio Frequency technology, which requires not only supporting infrastructures but human efforts to measure and calibrate the signal. Moreover, data collection for all locations is indispensable in existing methods, which in turn hinders their large-scale deployment. In this paper, we propose a novel neural network based architecture Graph Location Networks (GLN) to perform infrastructure-free, multi-view image based indoor localization. GLN makes location predictions based on robust location representations extracted from images through message-passing networks. Furthermore, we introduce a novel zero-shot indoor localization setting and tackle it by extending the proposed GLN to a dedicated zero-shot version, which exploits a novel mechanism Map2Vec to train location-aware embeddings and make predictions on novel unseen locations. Our extensive experiments show that the proposed approach outperforms state-of-the-art methods in the standard setting, and achieves promising accuracy even in the zero-shot setting where data for half of the locations are not available. The source code and datasets are publicly available at https://github.com/coldmanck/zero-shot-indoor-localization-release.Comment: Accepted at ACM MM 2020. 10 pages, 7 figures. Code and datasets available at https://github.com/coldmanck/zero-shot-indoor-localization-releas

A method to measure the resonance transitions between the gravitationally bound quantum states of neutrons in the GRANIT spectrometer

We present a method to measure the resonance transitions between the gravitationally bound quantum states of neutrons in the GRANIT spectrometer. The purpose of GRANIT is to improve the accuracy of measurement of the quantum states parameters by several orders of magnitude, taking advantage of long storage of Ultracold neutrons at specula trajectories. The transitions could be excited using a periodic spatial variation of a magnetic field gradient. If the frequency of such a perturbation (in the frame of a moving neutron) coincides with a resonance frequency defined by the energy difference of two quantum states, the transition probability will sharply increase. The GRANIT experiment is motivated by searches for short-range interactions (in particular spin-dependent interactions), by studying the interaction of a quantum system with a gravitational field, by searches for extensions of the Standard model, by the unique possibility to check the equivalence principle for an object in a quantum state and by studying various quantum optics phenomena

Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer

Background Cancer increases the risk of thromboembolic events even while on anticoagulation. Objectives To compare the efficacy and safety of low molecular weight heparin (LMWH) and oral anticoagulants for the long-term treatment of venous thromboembolism (VTE) in patients with cancer. Search strategy A comprehensive search for studies of anticoagulation in cancer patients including a February 2010 electronic search of: the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE and ISI Web of Science. Selection criteria Randomized controlled trials (RCTs) comparing long-term treatment with LMWH versus oral anticoagulants (vitamin K antagonist (VKA) or ximelagatran) in patients with cancer and symptomatic objectively-confirmed VTE. Data collection and analysis Using a standardized data form we extracted data on methodological quality, participants, interventions and outcomes of interest: survival, recurrent VTE, major bleeding, minor bleeding, thrombocytopenia and postphlebitic syndrome. We assessed the quality of evidence at the outcome level following the GRADE approach. Main results Of 8187 identified citations, nine RCTs were eligible and reported data for 1908 patients with cancer. Meta-analysis of seven RCTs showed that LMWH, compared to VKA provided no statistically significant survival benefit (hazard ratio (HR) 0.96; 95% confidence interval (CI) 0.81 to 1.14) but a statistically significant reduction in VTE (HR 0.47; 95% CI 0.32 to 0.71). Other results did not exclude a beneficial or harmful effect of LMWH compared to VKA for the outcomes of major bleeding (RR 1.05; 95% CI 0.53 to 2.10) or thrombocytopenia (RR 1.02; 95% CI 0.60 to 1.74). The quality of evidence was low for mortality, major bleeding and minor bleeding and moderate for recurrent VTE. One RCT comparing six months extension of anticoagulation with 18 months ximelagatran 24 mg twice daily versus placebo found a reduction in VTE (HR 0.16; 95% CI 0.09 to 0.30) but did not exclude beneficial or harmful effects for the outcomes of mortality and bleeding. One RCT, comparing dabigatran to VKA, did not exclude beneficial or harmful effect of one agent over the other. Authors' conclusions For the long-term treatment of VTE in patients with cancer, LMWH compared to VKA reduces venous thromboembolic events but not death. The decision for a patient with cancer and VTE to start long-term LMWH versus oral anticoagulation should balance the benefits and downsides and integrate the patient's values and preferences for the important outcomes and alternative management strategies

Mortality and pulmonary complications in patients undergoing surgery with perioperative sars-cov-2 infection: An international cohort study

Background The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on postoperative recovery needs to be understood to inform clinical decision making during and after the COVID-19 pandemic. This study reports 30-day mortality and pulmonary complication rates in patients with perioperative SARS-CoV-2 infection. Methods This international, multicentre, cohort study at 235 hospitals in 24 countries included all patients undergoing surgery who had SARS-CoV-2 infection confirmed within 7 days before or 30 days after surgery. The primary outcome measure was 30-day postoperative mortality and was assessed in all enrolled patients. The main secondary outcome measure was pulmonary complications, defined as pneumonia, acute respiratory distress syndrome, or unexpected postoperative ventilation. Findings This analysis includes 1128 patients who had surgery between Jan 1 and March 31, 2020, of whom 835 (740%) had emergency surgery and 280 (248%) had elective surgery. SARS-CoV-2 infection was confirmed preoperatively in 294 (261%) patients. 30-day mortality was 238% (268 of 1128). Pulmonary complications occurred in 577 (512%) of 1128 patients; 30-day mortality in these patients was 380% (219 of 577), accounting for 817% (219 of 268) of all deaths. In adjusted analyses, 30-day mortality was associated with male sex (odds ratio 175 [95% CI 128-240], p<00001), age 70 years or older versus younger than 70 years (230 [165-322], p<00001), American Society of Anesthesiologists grades 3-5 versus grades 1-2 (235 [157-353], p<00001), malignant versus benign or obstetric diagnosis (155 [101-239], p=0046), emergency versus elective surgery (167 [106-263], p=0026), and major versus minor surgery (152 [101-231], p=0047). Interpretation Postoperative pulmonary complications occur in half of patients with perioperative SARS-CoV-2 infection and are associated with high mortality. Thresholds for surgery during the COVID-19 pandemic should be higher than during normal practice, particularly in men aged 70 years and older. Consideration should be given for postponing non-urgent procedures and promoting non-operative treatment to delay or avoid the need for surgery. Funding National Institute for Health Research (NIHR), Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, NIHR Academy, Sarcoma UK, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research

Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

Background: The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on postoperative recovery needs to be understood to inform clinical decision making during and after the COVID-19 pandemic. This study reports 30-day mortality and pulmonary complication rates in patients with perioperative SARS-CoV-2 infection. Methods: This international, multicentre, cohort study at 235 hospitals in 24 countries included all patients undergoing surgery who had SARS-CoV-2 infection confirmed within 7 days before or 30 days after surgery. The primary outcome measure was 30-day postoperative mortality and was assessed in all enrolled patients. The main secondary outcome measure was pulmonary complications, defined as pneumonia, acute respiratory distress syndrome, or unexpected postoperative ventilation. Findings: This analysis includes 1128 patients who had surgery between Jan 1 and March 31, 2020, of whom 835 (74·0%) had emergency surgery and 280 (24·8%) had elective surgery. SARS-CoV-2 infection was confirmed preoperatively in 294 (26·1%) patients. 30-day mortality was 23·8% (268 of 1128). Pulmonary complications occurred in 577 (51·2%) of 1128 patients; 30-day mortality in these patients was 38·0% (219 of 577), accounting for 81·7% (219 of 268) of all deaths. In adjusted analyses, 30-day mortality was associated with male sex (odds ratio 1·75 [95% CI 1·28–2·40], p\textless0·0001), age 70 years or older versus younger than 70 years (2·30 [1·65–3·22], p\textless0·0001), American Society of Anesthesiologists grades 3–5 versus grades 1–2 (2·35 [1·57–3·53], p\textless0·0001), malignant versus benign or obstetric diagnosis (1·55 [1·01–2·39], p=0·046), emergency versus elective surgery (1·67 [1·06–2·63], p=0·026), and major versus minor surgery (1·52 [1·01–2·31], p=0·047). Interpretation: Postoperative pulmonary complications occur in half of patients with perioperative SARS-CoV-2 infection and are associated with high mortality. Thresholds for surgery during the COVID-19 pandemic should be higher than during normal practice, particularly in men aged 70 years and older. Consideration should be given for postponing non-urgent procedures and promoting non-operative treatment to delay or avoid the need for surgery. Funding: National Institute for Health Research (NIHR), Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, NIHR Academy, Sarcoma UK, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research